These genes are associated with hereditary breast and ovarian cancer (BRCA1, BRCA2), Lynch syndrome (MLH1, MSH2, MSH6, PMS2), and her2/neu mutations in breast cancer (ERBB2). This evidence concerns the gene ERBB2 and breast carcinoma.